Polycystic Ovary Syndrome Is Associated With Atherogenic Changes in Lipoprotein Particle Number and Size Independent of Body Weight

    February 2011 in “ Clinical Endocrinology ”
    Seema Sidhwani, Bert Scoccia, Shwetha Sunghay, Chantale N. Stephens-Archer, Theodore Mazzone, Susan Sam
    Image of study
    TLDR Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.
    The study, involving 50 premenopausal women—25 with polycystic ovary syndrome (PCOS) and 25 without—demonstrated that PCOS is associated with atherogenic changes in lipoprotein particle number and size, which are independent of body weight. Women with PCOS had increased numbers of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) particles, decreased high-density lipoprotein (HDL) size, and borderline decreased LDL size. These changes persisted after adjusting for ethnicity, alcohol and tobacco use, and exercise. Bioavailable testosterone was identified as the only predictor of LDL cholesterol, triglycerides, VLDL, and LDL particle number, while sex hormone-binding globulin (SHBG) predicted LDL and HDL size. The study concluded that PCOS contributes to an increased cardiovascular disease risk through lipoprotein profile changes more closely related to androgens than to fasting insulin levels.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    1 / 1 results